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Abstract
Ayahuasca is an Amazonian psychoactive plant beverage containing the serotonergic 5-HT2A agonist N,N-dimethyltryp-
tamine (DMT) and monoamine oxidase-inhibiting alkaloids (harmine, harmaline and tetrahydroharmine) that render it orally
active. Ayahuasca ingestion is a central feature in several Brazilian syncretic churches that have expanded their activities to
urban Brazil, Europe and North America. Members of these groups typically ingest ayahuasca at least twice per month. Prior
research has shown that acute ayahuasca increases blood flow in prefrontal and temporal brain regions and that it elicits
intense modifications in thought processes, perception and emotion. However, regular ayahuasca use does not seem to
induce the pattern of addiction-related problems that characterize drugs of abuse. To study the impact of repeated
ayahuasca use on general psychological well-being, mental health and cognition, here we assessed personality,
psychopathology, life attitudes and neuropsychological performance in regular ayahuasca users (n = 127) and controls
(n = 115) at baseline and 1 year later. Controls were actively participating in non-ayahuasca religions. Users showed higher
Reward Dependence and Self-Transcendence and lower Harm Avoidance and Self-Directedness. They scored significantly
lower on all psychopathology measures, showed better performance on the Stroop test, the Wisconsin Card Sorting Test
and the Letter-Number Sequencing task from the WAIS-III, and better scores on the Frontal Systems Behavior Scale. Analysis
of life attitudes showed higher scores on the Spiritual Orientation Inventory, the Purpose in Life Test and the Psychosocial
Well-Being test. Despite the lower number of participants available at follow-up, overall differences with controls were
maintained one year later. In conclusion, we found no evidence of psychological maladjustment, mental health
deterioration or cognitive impairment in the ayahuasca-using group.
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Introduction
Ayahuasca is a psychotropic tea obtained from Banisteripsis caapi
and Psychotria viridis, two plant species native to the Amazon Basin
[1]. Ayahuasca has traditionally played a central role in
Amazonian shamanism and in more recent times it has become
the sacrament of various syncretic religious groups that have
exported its use and increased its popularity worldwide [2].
Attesting this expansion, the anthropological and ethnographical
bibliography on its modern religious use includes more than 400
scientific papers, book chapters, PhD theses and articles in popular
magazines written in ten different languages. Some estimate there
are around 20,000 regular religious ayahuasca users in the twenty-
three countries where the so called ‘‘ayahuasca religions’’ are
present [3]. In the US, Canada, Holland, and Brazil, federal laws
protect the religious use of ayahuasca and in Peru it has recently
been declared part of the National Cultural Heritage [4].
Despite the legal protection enjoyed in some countries,
ayahuasca use is not without controversy. P. viridis contains the
hallucinogen N,N-dimethyltryptamine (DMT; [5]), a compound
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listed in the 1971 Convention on Psychotropic Substances.
However, no plants (natural materials) containing DMT are at
present controlled under the said convention [6]. Analogously to
other serotonergic hallucinogens, DMT is thought to elicit its
psychotropic effect through stimulation of the 5-HT2A receptors
[7,8]. However, unlike other hallucinogens DMT is not active
when administered orally, as it is readily metabolized to 3-
indoleacetic acid by monoamine oxidase [9]. However, B. caapi
contains harmala alkaloids that reversibly block the metabolic
breakdown of DMT, leading to psychoactivity [10,11].
Clinical studies have shown that ayahuasca induces a modified
state of awareness that includes dream-like imagery with eyes
closed, increased insight and intense emotions [10,12]. CNS effects
can also evidenced as time-dependent increases in the relative
energy of the beta band of the electroencephalogram [11,13,14].
Effects start between 30 and 45 minutes, peak between 90 and
120 minutes and are resolved by 240 minutes [10,12]. Physiolog-
ical modifications include moderate increases in blood pressure,
elevations of blood cortisol and prolactine and lymphocyte
redistribution [10,11,12,14]. Pharmacodynamic changes closely
follow the plasma concentrations of DMT, which peaks at 90–
120 min and shows an elimination half-life of one hour [10].
The increasing number of individuals using ayahuasca on a
regular basis has raised public health concerns [2]. Drugs of abuse
such as heroin, cocaine, alcohol or amphetamines share a
common neurobiological mechanism which involves the so-called
‘‘neural reward system’’, inducing functional changes in brain
structures related to pleasure such as the striatum and the
dopaminergic ventral-tegmental area [15]. The activation of this
neural circuit is considered to play a crucial role in modulating the
consequences of drug abuse, which may include psychological,
medical, legal, employment and family problems [16]. DMT, on
the other hand is a serotonergic drug, binding to postsynaptic 5-
HT2A receptors [17,18]. Although some studies have found that
hallucinogenic drugs like psilocybin or LSD (lysergic acid
diethylamide) may also modulate dopaminergic neurotransmission
[19–21], a neuroimaging study using SPECT (Single Photon
Emission Computerized Tomography) found that ayahuasca
increases regional brain blood flow in frontal and paralimbic
areas [22], but did not find any changes in reward-related regions
such as the striatum or the midbrain. Nevertheless, in a prior study
by our group [23], we assessed addiction severity in two samples of
long-term members of the ayahuasca religions and we did not find
participants to be ‘‘addicted’’ to the tea. Nor did we observe the
deleterious psychosocial effects commonly associated with drugs of
abuse.
Despite the above findings, the question remains as to whether
the continued use of ayahuasca may have an impact on personality
and general mental health (negative effects other than those
directly related to addiction) and cognition. On the phenomeno-
logical level, the acute cognitive, emotional and perceptual
modifications brought about by ayahuasca are quite intense [11]
and have been described to potentially cause psychiatric compli-
cations in some individuals [24,25]. From a biological perspective,
ayahuasca induces activation of prefrontal and temporal regions of
the brain [22,26], an activatory effect probably mediated by
glutamate release [7,8,27]. Mental health and cognitive perfor-
mance of long-term ayahuasca users has not been well-studied,
and the few papers published to date on the impact of chronic
ayahuasca use have failed to detect negative neuropsychological
[28,29] or psychopathological [30,31] effects. For a review see
Bouso and Riba [32].
In this paper we report the results of a study specifically
designed to evaluate personality, life attitudes, mental health and
neuropsychological performance in a relatively large number of
ritual ayahuasca users and their matched controls. The investiga-
tion involved one initial assessment and a follow-up one year later.
Methods
1. Participants
Participants belonging to ayahuasca-using groups were recruit-
ed after a meeting between the research team and members of
several Brazilian ayahuasca churches. The inclusion criterion was
to have been taking ayahuasca for a minimum of 15 years with a
frequency of at least twice a month. Control subjects were
recruited to match the age, sex and educational level of ayahuasca
users. Controls were only accepted if they had taken ayahuasca a
maximum of 5 times. Care was taken to make sure that the
majority of individuals in the comparison groups were also actively
practicing some form of religion but without the ayahuasca-using
component. Participants were distributed as follows:
1.1. Jungle sample. Ayahuasca group: 56 ayahuasca users
from a community within the Amazon rain forest.
This group was recruited from Ce´u do Mapia´, a community of
religious ayahuasca users in the Brazilian State of Amazonas. Ce´u
do Mapia´ is the headquarters of the Centro Ecle´tico da Fluente
Luz Universal Raimundo Irineu Serra (CEFLURIS), an important
ayahuasca church within the Santo Daime movement, with
branches throughout South-America, the US, Canada, Europe
and Japan. Ce´u do Mapia` was established in 1983 by the founder
of CEFLURIS, Sebastia˜o Mota de Melo (known as Padrinho
Sebastia˜o), and it has since received migrants from other parts of
Brazil, South-America, and overseas. Its current population is
estimated at 600 and it includes men and women of all ages and
children. CEFLURIS is a church of the Santo Daime, a syncretic
religion that combines Christian, indigenous, Afro-American and
esoteric traditions. The experiences attained by followers during
rituals are interpreted as contact with ‘God’ and the ‘spirits’ and
other archetypical ‘entities’ from their religious beliefs and
doctrine (for a comprehensive study of the Santo Daime religion
see MacRae [33]). The mean frequency of ritual attendance in this
group was about six times per month. The estimated average
lifetime exposure to ayahuasca in this group ranged between 360
and 1080 times.
Control group: Ce´u do mapia´ comparison group. A
group of 56 controls was recruited from Boca do Acre, the nearest
town to the Ce´u do Mapia´ community. Boca do Acre is located
deep in the heart of the Amazon rain forest, has a strong
agricultural economy, and is a typical small Amazonian town of
about 7,000 inhabitants. Of the 56 controls, only 7 had ever
ingested ayahuasca. Five participants had taken it once and the
other two had taken it two times.
1.2. Urban sample. Ayahuasca group: Urban-based aya-
huasca users.
This group consisted of 71 members of another ayahuasca
religious group called Barquinha, located in the city of Rio Branco.
The city of Rio Branco, the capital of the State of Acre, has about
150,000 inhabitants and it hosts other branches of the Santo
Daime and other ayahuasca churches such as the Unia˜o do
Vegetal and the Alto Santo. The frequency with which Barquinha
members attended rituals in our sample was about eight times per
month. The estimated average lifetime exposure to ayahuasca in
this group ranged between 360 and 1440 times.
Control group: Urban-based comparison group. Fifty-
nine controls were recruited in the city of Rio Branco as a
comparison group. Of the 59, only 4 had ever ingested ayahuasca
and they had all taken it once.
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The study was conducted in accordance with the Declarations
of Helsinki, as amended in Edinburgh 2000, and subsequent
updates. All subjects signed an informed consent form prior to
participation. The study was approved by the human research
committee of UNINORTE University (Rio Branco, Acre State,
Brazil).
2. Study Variables
2.1. Sociodemographic variables. Age (years), sex (male/
female) and years of education were used to match study and
control groups. Additional sociodemographic indicators such as
employment status (according to Hollingshead’s categories [23]),
race, marital status and religion were recorded for comparison
purposes.
2.2. Personality traits: Temperament and character
inventory – TCI. The TCI is based on the psychobiological
model of personality developed by Cloninger and coworkers [34].
The temperament dimensions are assumed to be independently
inheritable and to manifest in early development, while the
character dimensions are assumed to be more influenced by
sociocultural learning and maturation. The TCI has 240 items
with a true/false option response. The four primary dimensions of
temperament and their facets are: Harm Avoidance (HA): HA1-
Anticipatory Worry vs. Uninhibited Optimism; HA2-Fear of
Uncertainty vs. Confidence; HA3-Shyness with Strangers vs.
Gregariousness; HA4-Fatigability and Asthenia vs. Vigor; Novelty
Seeking (NS): NS1-Exploratory Excitability vs. Stoic Rigidity;
NS2-Impulsiveness vs. Reflection; NS3-Extravagance vs. Reserve;
NS4-Disorderliness vs. Regimentation; Reward Dependence (RD):
RD1-Sentimentality vs. Insensitivity; RD3-Attachment vs. De-
tachment; RD4-Dependence vs. Independence; and Persistence
(P). The three dimensions of character are: Self-Directedness (SD):
SD1-Responsibility vs. Blaming; SD2-Purposefulness vs. Lack of
Goal-Direction; SD3-Resourcefulness; SD4-Self-Acceptance vs.
Self-Striving; SD5-Congrugent Second Nature; Cooperativeness
(C): C1-Social Acceptance vs. Social Intolerance; C2-Empathy vs.
Social Disinterest; C3-Helpfulness vs. Unhelpfulness; C4-Com-
passion vs. Revengefulness; C5-Integrated Conscience; and Self-
Transcendence (ST): ST1-Self-Forgetfulness vs. Self-Conscious
Experience; ST2-Transpersonal Identification vs. Self-Isolation;
ST3-Spiritual Acceptance vs. Rational Materialism. In this study
we used the Brazilian Portuguese version of the TCI adapted by
Fuentes and coworkers [35].
2.3. Psychopathological status: The Symptom Check-List-
90-Revised – SCL-90-R. The SCL-90-R [36] is a self-report
questionnaire that assesses 9 psychopathological symptomatic
dimensions including 90 likert-type items that are scored from 0 to
4: Somatization (SOM), Obsessive-Compulsive (O–C), Interpersonal
Sensitivity (I–S), Depression (DEP), Anxiety (ANX), Hostility (HOS),
Phobic Anxiety (PHOB), Paranoid Ideation (PAR), and Psychoticism
(PSY). The scale also provides 3 additional psychopathological
indices: General Severity Index (GSI), Positive Symptoms Distress
Index (PSDI), and Positive Symptoms Total (PST). For all the scales
higher scores imply worse symptomatology. In this study we used the
Brazilian Portuguese version adapted by Tosello [37].
2.4. Neuropsychological performance and behavior. The
Stroop Color and Word Test. The Stroop test [38] assesses
conflict monitoring and resolution (resistance to interference),
cognitive tasks involving the anterior cingulate-dorsolateral pre-
frontal system and the rostroventral prefrontal cortex [39]. In this
test subjects must first read a list of color names (‘‘red’’, ‘‘green’’,
‘‘blue’’) written in black ink. When this is completed, a list of ‘‘X’’
printed in different colors (red, green, blue) is presented and the
subject must indicate the color in which each element is printed.
Finally, a third list is presented to the participant containing a list
of color names (‘‘red’’, ‘‘green’’, ‘‘blue’’) but printed this time in an
incongruent ink color. As with the second list, the participant is
asked to indicate the color in which each element is printed. The
numbers of correctly read (first list) and correctly reported items
(lists two and three) in 45 seconds are recorded. Dependent
variables are the total number of words read (W), the total number
of correctly identified colors in the second list (C) and the total
number of color incongruent words read (IW). Finally, a
‘‘Resistance to Interference’’ measure (RI) is calculated according
to the following formula: RI = IW-(CxW/C+W). Better perfor-
mance is reflected as higher scores on IW and RI.
The Wisconsin Card Sorting Test (WCST)
The WCST [40] is considered a measure of executive function
in that it requires strategic planning, organized searching, the
ability to use environmental feedback to shift cognitive set, goal-
oriented behavior, and the ability to modulate impulsive
responding [41]. Anatomically, the WCST involves the dorso-
and ventrolateral prefrontal cortices [42]. The test consists of 4
stimulus cards placed in front of the subject. The first has a printed
red triangle, the second two green stars, the third three yellow
crosses, and the fourth four blue circles. Subjects are then given
two decks each containing 64 response cards, which have designs
similar to those on the stimulus card, varying in color, geometric
form, and number. Subjects are told to match each of the cards
and are given feedback as to whether they are doing right or
wrong. The sorting rule is changed at fixed intervals but no
warning is provided that the sorting rule has changed. There is no
time limit to perform the test. The following dependent variables
were assessed: Number of Total Errors, Number of Perseverative
Errors, Number of Non-Perseverative Errors, Number of
Achieved Categories and Failures to Maintain Set.
The Letter-NumberSequencing (LNS) from the WAIS-III
The LNS [43] is a measure of working memory, a task involving
dorso-, ventrolateral and orbitofrontal prefrontal cortices [44].
Subjects are verbally presented with a random series of numbers
and letters which they have to report back in a specified order, i.e,
numbers in ascending order and letters in alphabetical order.
Series of increasing length are presented to the subject until an
error is committed. The score is the maximum number of
elements in the series correctly reported by the participant. Higher
scores indicate better performance.
The Frontal Systems Behaviour Scales (FrSBe)
The FrSBe [45] is a rating scale designed to measure behaviors
associated with damage to the frontal lobes and systems of the brain.
This questionnaire was used to assess hypothetical frontal lobe
alterations that could potentially go undetected with classical
neuropsychological tests but that could have an impact on everyday
life. The questionnaire comprises 46 likert-type items with 5
response options. The items are distributed into 3 subscales:
Apathy/Akinesia (14 items), Disinhibition/Emotional Dysregula-
tion (15 items), and Executive Dysfunction (17 items). Higher scores
reflect worse frontal function. A global score is computed adding up
the scores of the individual scales. We used the self-report version of
the scale adapted to Brazilian Portuguese by our team.
2.5. Life Attitudes and Psychosocial Well-Being
The spiritual orientation inventory (SOI). The SOI [46]
is a measure of spirituality based on the humanistic model and is
designed to assess the spirituality of those affiliated with traditional
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religion. It is a 85-Likert-type item self-report questionnaire. Items
are distributed into nine major components: Transcendent
Dimension, Meaning and Purpose in Life, Mission in Life,
Sacredness of Life, Material Values, Altruism, Idealism, Aware-
ness of the Tragic, and Fruits of Spirituality. Each item has 7
response options The questionnaire was adapted into Brazilian
Portuguese by our team.
The purpose in life test (PLT). The PLT [47] is a measure
of a subject’s perceived ‘‘meaning of life’’ versus ‘‘existential
vacuum’’ and is based on Victor Frankl’s Logotherapy. It consists
of 20 items, each rated on a 7-point scale ranging from 1 (low
purpose) to 7 (high purpose). The total score can range from 20
(low purpose) to 140 (high purpose). The questionnaire was
adapted into Brazilian Portuguese by our team.
The psychosocial well-Being (BIEPS-Bienestar
Psicosocial). The BIEPS [48] is a measure of psychosocial
well-being composed of a global and four specific dimensions: Self-
Acceptance, Autonomy, Psychosocial Bonds, and Projects. It
consists of 13 items with three response options (agree, nor agree
nor disagree, disagree). The questionnaire was adapted into
Brazilian Portuguese by our team.
3. Statistical Analysis
3.1. Sociodemographic variables. In order to match the
samples, age and years of education were compared using
independent samples Student’s t test. Although not a matching
variable, employment status was also compared between users and
controls by means of Student’s t test. The distribution of gender,
race, marital status and religion between ayahuasca users and
controls in each sample were analyzed by means of x2.
3.2. Personality, psychopathology, neuropsychology and
life attitude variables. Due to the longitudinal nature of the
design, we were unable to contact all the participants at the second
assessment. Also, due to the field nature of the study, data from
some tests was lost for some subjects. In order to maximize sample
size and statistical power, we used the data from all subjects
available for a given test.
Individual and group scores were obtained for the different
variables. For each variable a two-way analysis of variance
(ANOVA) was performed with two between-subjects factors, i.e.,
Group (ayahuasca users vs. controls) and Sample (jungle vs. urban).
Each ANOVA was performed in the first assessment and in the
second assessment 8–12 months later. Results were considered
significant for p values ,0.05.
Results
1. Sociodemographic Variables
Results concerning the sociodemographic characteristics of the
samples are presented in Table 1.
The Jungle sample consisted in the first assessment of 56 regular
ayahuasca users and 56 controls. No significant differences were
found between ayahuasca users and controls in sex, age, years of
education or income either in the first or second assessment. In the
Jungle sample, a statistical difference was noted in employment,
with the comparison group being more qualified according to the
Hollingshead categories [23]. A total of 88 volunteers from the
Jungle sample were assessed in a follow-up one year later: 39 from
the ayahuasca group and 49 from the comparison group. No
statistical differences were found. Other demographic data such as
race, marital status, and religion are also shown in the table. Both
ayahuasca users and controls were mainly of whites and mestizos.
The predominant marital status was ‘‘never married’’ in the
ayahuasca users, and ‘‘married’’ in the controls. All ayahuasca
users in the Jungle sample were members of CEFLURIS, and all
but 3 individuals from the control group were followers of other
Christian religions (Catholicism followed by Protestantism).
The Urban sample consisted in the first assessment of 71
ayahuasca users and 59 controls. In the second assessment 58
volunteers (39 ayahuasca users and 19 comparisons) were
evaluated. We found no significant differences between the groups
for sex, age, years of education, income, employment status or
income variables, either in the first or second assessment.
Participants in both groups were mainly whites and mestizos.
Regarding marital status, most volunteers in both groups were
either ‘‘never married’’ or ‘‘married’’. All ayahuasca users in the
Urban sample were members of Barquinha. Most comparison
subjects defined themselves as followers of traditional Christian
religions (Catholicism followed by Protestantism).
2. Personality Traits: Temperament and Character
Inventory – TCI
Mean (SD) scores on the different TCI subscales for each
sample, group, and time point are shown in Table 2.
In the first assessment, the two-way ANOVA on temperament
dimensions showed a main effect of Group (ayahuasca users vs.
controls) for Harm Avoidance [F(1,223) = 17.73; p,0.001], with
lower values for ayahuasca users than controls and for Reward
Dependence [F(1,223) = 6.98; p = 0.009], with higher values for
ayahuasca users. Despite lower mean values for Novelty Seeking,
the overall comparison was not significant. No significant main
effect was found either for Persistence and a trend to significance
was found for the interaction between Group and Sample
[F(1,223) = 3.62; p = 0.059].
The effect on Harm Avoidance was mainly driven by significantly
lower scores on Anticipatory Worry [F(1,223) = 12.28; p,0.001],
Shyness [F(1,223) = 9.28; p = 0.003] and Fatigability and Asthenia
[F(1,223) = 6.23; p = 0.013]. This latter subscale also showed a
significant effect of Sample [F(1,223) = 4.17; p = 0.042], with values
higher in the Jungle sample.
Despite the non-significant differences found in the Novelty
Seeking dimension, analysis of the different facets comprising the
scale found significantly lower scores on Disorderliness for the
ayahuasca-using individuals [F(1,223) = 4.50; p = 0.035].
The effect on Reward Dependence was driven by significantly
higher scores for ayahuasca users in Attachment [F(1,223) = 7.68;
p = 0.006] and Dependence [F(1,223) = 9.52; p = 0.002]. Signifi-
cant Sample by Group interactions were found for Attachment
[F(1,223) = 4.10; p = 0.044] and Dependence [F(1,223) = 4.17;
p = 0.042], with higher differences between ayahuasca users and
controls in the Jungle sample.
The analysis of first assessment scores on TCI character
dimensions showed significantly lower scores for ayahuasca users
in Self-Directedness [F(1,223) = 9.56; p = 0.002], no differences in
Cooperativeness and significantly higher scores in Self-Transcen-
dence.
The significant effect on Self-Directedness was driven by lower
scores in Responsibility [F(1,223) = 8.36; p = 0.004]; Purposefulness
[F(1,223) = 4.19; p = 0.042], Resourcefulness [F(1,223) = 12.32;
p = 0.001], and Self-Acceptance [F(1,223) = 12.67; p,0.001]. No
Group effects were found for Congruent Second Nature. The
analysis of Group by Sample interactions indicated that effects in the
Jungle sample were significantly larger for Resourcefulness
[F(1,223) = 3.94; p,0.05] and showed a trend for Self-Acceptance
[F(1,223) = 3.15; p = 0.077].
Despite no overall effect on Cooperativeness, the detailed analysis
of the facets comprising this dimension showed a significant Group
effect for Helpfulness [F(1,223) = 7.60; p = 0.006] and Compassion
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[F(1,223) = 4.99; p = 0.026]. Compared to controls, ayahuasca users
showed higher and lower scores on these two scales, respectively.
Self-Transcendence scores were significantly higher in ayahuasca
users than in controls [F(1,223) = 25.91; p,0.001]. All three facets
assessed in this character dimension were found to be significantly
higher, specifically Self-Forgetfulness [F(1,223) = 4.48; p = 0.035],
Transpersonal Identification [F(1,223) = 24.10; p,0.001], and
Spiritual Acceptance [F(1,223) = 30.01; p,0.001].
In the second assessment, lower scores for Harm Avoidance
were again observed [F(1,116) = 4.81; p = 0.030] but not for
Reward Dependence. Again no differences were found for Novelty
Seeking and Persistence. The effect on Harm Avoidance was
mainly driven by significantly lower scores on Anticipatory Worry
[F(1,116) = 5.93; p = 0.016], Fear of Uncertainly [F(1,116) = 4.29;
p = 0.041], an effect not observed in the first assessment, and
Shyness [F(1,116) = 5.02; p = 0.027].
Character dimensions again showed lower scores for ayahuasca
users on Self-Directedness [F(1,116) = 11.87; p = 0.001], no differ-
ences on Cooperativeness and significantly higher scores on Self-
Transcendence [F(1,116) = 7.3; p = 0.008].
Lower Self-Directedness was due to lower scores on Responsibility
[F(1,116) = 24.75; p,0.001] and Self-Acceptance [F(1,116) = 12.23;
p = 0.001]. Again, despite no overall effect on Cooperativeness,
Helpfulness remained higher in the ayahuasca-using group
[F(1,116) = 4.20; p = 0.043] but no differences were seen in
Compassion.
The maintained higher scores on Self-Transcendence could be
attributed to Transpersonal Identification [F(1,116) = 7.56;
p = 0.007] and Spiritual Acceptance [F(1,116) = 17.94; p,0.001],
but not to Self-Forgetfulness.
3. Psychopathological Status: The Symptom Check-List-
90-Revised – SCL-90-R
Mean (SD) scores on the 9 SCL-90-R dimensions for each
sample, group, and time point are shown in Table 3.
Table 1. Sociodemographic data as means (standard deviation) for age, years of education, employment and income and as
frequencies for race, marital status and religion.
First Assessment Second Assessment
Jungle Sample Urban Sample Jungle Sample Urban Sample
Ayahuasca Controls Ayahuasca Controls Ayahuasca Controls Ayahuasca Controls
Matching variables
N (men/women) 56 (29/27) 56 (24/32) 71 (33/38) 59 (31/28) 39 (19/20) 49 (19/30) 39 (21/18) 19 (7/12)
Age 36 (13.46) 33.71 (12.53) 37.32 (12.77) 38.15 (12.22) 39.21 (12.90) 34.69 (12.25) 38.82 (13.06) 40.63 (11.63)
Years Education 10.55 (3.45) 10.96 (4.35) 10.27 (3.90) 11.08 (3.30) 11.08 (3.19) 11.51 (4.40) 10.87 (4.16) 12.53 (3.03)
Additional sociodemographic variables
Employment 6.04 (1.68) 4.91 (2.58)** 5.80 (2.63) 5.73 (2.61) 5.79 (1.61) 5.08 (2.70) 5.82 (2.59) 5.32 (2.43)
Income 329.46 (414.06) 555.61 (1013.85) 738.11 (943.86) 1028.93 (1072.83) 519.74 (627.52) 642.96 (647.71) 713.95 (1001.25) 1065.95 (939.92)
Race
White 40 (71.42%) 11 (19.64%){{{ 38 (53.52%) 34 (57.63%) 30 (76.92%) 10 (20.41%){{{ 23 (58.98%) 11 (57.89%)
Mestizos 15 (26.78%) 45 (80.36) 31 (43.66%) 21 (35.59%) 9 (23.07%) 39 (79.59%) 15 (38.46%) 6 (31.59%)
Asian 1 (1.78%) – 1 (1.41%) 1 (1.69%) – – – 1 (5.26%)
Black – – 1 (1.41%) 3 (5.08%) – – 1 (2.56%) 1 (5.26%)
Marital status
Married 13 (23.21%) 33 (58.93%){{ 25 (35.21%) 17 (28.82%) 14 (35.90%) 31 (63.26%){ 23 (58.97%) 8 (42.1%)
Remarried 1 (1.79%) 1 (1.79%) 2 (2.82%) 1 (1.69%) – 1 (2.05%) 1 (2.56%) –
Separated 7 (12.5%) 2 (3.57%) 10 (14.08%) 9 (15.25%) 7 (17.94%) 5 (10.20%) 4 (10.26%) 5 (26.32%)
Divorced 4 (7.14%) – 6 (8.45%) 5 (8.47%) 4 (10.26%) – – 1 (5.26%)
Never Married 31 (55.36%) 20 (35.71%) 28 (39.44%) 27 (45.77%) 14 (35.90%) 12 (24.49%) 11 (28.21%) 5 (26.32%)
Religion
Daime/Barquinha 56 (100%) –{{{ 71 (100%) –{{{ 39 (100%) –{{{ 39 (100%) –{{{
Catholics – 35 (62.5%) – 30 (58%) – 33 (67.35%) – 12 (63.16%)
Protestants – 15 (26.78%) – 17 (28.81%) – 10 (20.41%) – 7 (36.84%)
Others – 3 (5.36%) – 2 (3.39%) – 3 (61.12%) – –
None – 3 (5.36%) – 10 (16.95%) – 3 (6.12%) – –
* = p,0.05;
** = p,0.01;
*** = p,0.001 in the Student’s t test.
{ = p,0.05;
{{ = p,0.01;
{{{ = p,0.001 in the x2 test (comparison includes multiple categories).
Asterisks and crosses indicate p values for between group (ayahuasca vs. controls) Student’s t tests (age, education, employment and income) and x2 tests (gender,
race, marital status and religion) at baseline and at follow up for the Jungle and Urban samples. Aya. = Ayahuasca-using group; Comp. = comparison group.
doi:10.1371/journal.pone.0042421.t001
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Table 2. TCI scales and subscales means (standard deviation).
First Assessment Second Assessment
ANOVA Jungle Sample Urban Sample ANOVA Jungle Sample Urban Sample
TCI
subscale df(1,223)
Ayahuasca
n=54
Controls
n=54
Ayahuasca
n=64
Controls
n=55 df(1,116)
Ayahuasca
n=36
Controls
n=39
Ayahuasca
n=30
Controls
n=15
HA F = 17.73;
p,0.001
14.69 (5.03) 18.30 (4.99) 15.41 (5.36) 17.53 (5.04) F = 4.81; p = 0.030 13.78 (5.87) 17.26 (5.35) 14.63 (6.32) 16.07 (4.95)
HA1 F = 12.28;
p,0.001
3.46 (2.13) 4.83 (2.03) 3.92 (1.93) 4.85 (2.25) F = 5.93; p = 0.016 3.17 (1.98) 4.67 (1.92) 3.83 (2.32) 4.27 (1.75)
HA2 F = 8.25;
p = 0.069
4.44 (1.65) 4.87 (1.82) 4.73 (1.48) 5.07 (1.31) F = 4.29; p = 0.041 4.36 (1.74) 5.10 (1.74) 4.60 (1.65) 5.20 (1.08)
HA3 F = 9.28;
p = 0.003
3.48 (1.99) 4.59 (1.59) 3.83 (1.78) 4.18 (1.84) F = 5.02; p = 0.027 3.44 (2.23) 4.51 (1.68) 3.30 (1.88) 3.93 (1.91)
HA4 F = 6.23;
p = 0.013
3.30 (1.73) 4.07 (1.97) 2.86 (2.18) 3.42 (2.10) F = 0.01; p = 0.912 2.81 (1.85) 2.95 (1.94) 2.90 (2.32) 2.67 (2.44)
NS F = 2.28;
p = 0.130
17.94 (4.67) 18.04 (4.74) 16.75 (4.82) 18.62 (5.26) F = 1.08; p = 0.300 17.58 (4.83) 17.79 (4.83) 17.30 (4.55) 15.13 (5.08)
NS1 F = 1.34;
p = 0.248
6.50 (1.80) 6.06 (1.64) 6.02 (1.86) 5.91 (1.83) F = 2.11; p = 0.149 6.58 (1.70) 6.13 (1.70) 6.63 (2.40) 6.00 (1.81)
NS2 F = 1.13;
p = 0.289
3.35 (2.05) 3.39 (1.78) 3.31 (1.99) 3.84 (2.11) F = 0.84; p = 0.360 3.11 (2.04) 3.15 (1.97) 3.23 (2.14) 2.47 (1.77)
NS3 F = 1.13;
p = 0.288
4.65 (1.89) 4.81 (2.35) 4.48 (2.09) 5.25 (2.18) F = 0.12; p = 0.729 4.53 (1.89) 4.95 (2.35) 4.53 (1.79) 4.40 (2.53)
NS4 F = 4.50;
p = 0.035
3.46 (1.63) 3.78 (1.68) 2.94 (1.77) 3.62 (1.95) F = 0.26; p = 0.609 3.36 (1.86) 3.62 (2.13) 2.90 (1.73) 2.27 (1.49)
RD F = 6.98;
p = 0.009
16.11 (4.15) 14.04 (2.90) 14.39 (3.33) 14.00 (3.55) F = 0.37; p = 0.547 15.56 (3.97) 14.36 (3.23) 14.67 (3.14) 15.07 (2.37)
RD1 F = 0.12;
p = 0.729
6.63 (1.93) 6.85 (1.64) 6.22 (1.61) 5.84 (1.76) F = 0.98; p = 0.325 6.56 (1.70) 6.74 (1.87) 6.23 (1.67) 6.73 (1.91)
RD3 F = 7.68;
p = 0.006
5.37 (2.09) 4.26 (1.84) 3.61 (1.54) 3.44 (1.46) F = 1.89; p = 0.172 5.36 (1.82) 4.36 (1.99) 3.83 (1.70) 3.87 (1.30)
RD4 F = 9.52;
p = 0.002
3.96 (1.26) 2.93 (1.40) 5.16 (1.70) 4.95 (1.64) F = 0.38; p = 0.537 4.11 (1.19) 3.18 (2.94) 5.03 (1.73) 5.47 (1.36)
P F = 2.21;
p = 0.139
5.39 (1.83) 4.56 (1.71) 4.63 (1.83) 4.73 (2.00) F = 0.13; p = 0.721 4.83 (2.08) 4.85 (1.68) 4.73 (1.74) 4.47 (1.55)
SD F = 9.56;
p = 0.002
21.94 (6.09) 25.76 (6.10) 20.91 (4.99) 22.09 (7.11) F = 11.87; p = 0.001 20.0 (5.83) 23.85 (7.35) 20.00 (4.50) 24.60 (7.13)
SD1 F = 8.36;
p = 0.004
2.91 (1.76) 3.69 (1.63) 3.80 (1.44) 3.58 (1.83) F = 24.75; p,0.001 2.64 (1.40) 3.67 (1.46) 2.57 (1.35) 4.27 (1.71)
SD2 F = 4.19;
p = 0.042
4.00 (1.35) 4.41 (1.39) 3.80 (1.20) 4.09 (1.22) F = 2.83; p = 0.095 3.58 (1.13) 3.97 (1.51) 3.77 (1.00) 4.20 (1.21)
SD3 F = 12.32;
p = 0.001
2.24 (1.24) 3.17 (1.38) 2.13 (1.09) 2.38 (1.35) F = 3.34; p = 0.070 2.03 (1.21) 2.61 (1.62) 2.00 (1.29) 2.27 (1.28)
SD4 F = 12.67;
p,0.001
5.57 (2.19) 7.15 (2.34) 5.11 (2.11) 5.64 (2.25) F = 12.23; p = 0.001 5.42 (2.35) 7.13 (2.28) 4.97 (2.34) 6.40 (2.10)
SD5 F = 0.012;
p = 0.913
7.11 (2.13) 7.39 (1.92) 6.80 (1.89) 6.58 (2.59) F = 2.70; p = 0.103 6.39 (1.82) 7.33 (3.88) 6.70 (1.50) 7.47 (2.59)
C F = 0.43;
p = 0.515
25.65 (2.40) 26.09 (2.75) 25.31 (3.01) 24.31 (4.38) F = 0.005; p = 0.947 25.11 (2.43) 26.23 (4.49) 25.30 (2.67) 24.27 (2.19)
C1 F = 1.71;
p = 0.192
5.65 (6.89) 5.02 (1.20) 5.11 (0.81) 4.53 (1.12) F = 0.053; p = 0.818 4.64 (0.93) 4.82 (1.07) 4.77 (0.73) 4.67 (0.61)
C2 F = 1.27;
p = 0.261
5.02 (1.11) 4.80 (1.15) 4.73 (1.25) 4.58 (1.45) F = 0.002; p = 0.962 5.22 (1.44) 5.08 (0.98) 5.03 (1.10) 5.20 (0.76)
C3 F = 7.60;
p = 0.006
5.57 (0.84) 5.26 (1.25) 5.42 (0.90) 4.98 (1.10) F = 4.20; p = 0.043 5.53 (0.91) 5.46 (0.85) 5.60 (1.07) 4.93 (0.70)
C4 F = 4.99;
p = 0.026
4.74 (1.28) 5.20 (1.45) 4.58 (1.26) 4.98 (1.81) F = 1.12; p = 0.292 4.50 (0.94) 5.36 (1.29) 4.47 (0.86) 4.07 (1.39)
C5 F = 0.08;
p = 0.773
5.59 (0.96) 5.91 (1.10) 5.47 (0.91) 5.24 (1.30) F = 3.49; p = 0.064 5.19 (0.99) 6.44 (2.51) 5.43 (1.01) 5.40 (0.99)
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Table 2. Cont.
First Assessment Second Assessment
ANOVA Jungle Sample Urban Sample ANOVA Jungle Sample Urban Sample
TCI
subscale df(1,223)
Ayahuasca
n=54
Controls
n=54
Ayahuasca
n=64
Controls
n=55 df(1,116)
Ayahuasca
n=36
Controls
n=39
Ayahuasca
n=30
Controls
n=15
ST F = 25.91;
p,0.001
22.80 (5.25) 19.28 (6.27) 21.02 (5.72) 16.64 (6.09) F = 7.3; p = 0.008 22.72 (5.85) 18.26 (6.99) 20.40 (4.76) 18.53 (5.60)
ST1 F = 4.48;
p = 0.035
7.17 (2.29) 6.65 (2.39) 6.28 (2.39) 5.47 (2.27) F = 0.51; p = 0.475 6.69 (2.65) 6.62 (3.66) 5.77 (2.24) 6.67 (2.59)
ST2 F = 24.10;
p,0.001
7.09 (1.71) 5.63 (2.38) 6.16 (2.36) 4.73 (2.30) F = 7.56; p = 0.007 7.08 (2.12) 5.72 (2.37) 6.43 (1.74) 5.47 (2.47)
ST3 F = 30.01;
p,0.001
8.54 (2.21) 7.35 (2.15) 8.58 (2.04) 6.44 (2.71) F = 17.94; p,0.001 8.94 (1.91) 7.08 (2.46) 8.20 (1.99) 6.40 (2.59)
The ANOVA column shows results for the main effect of Group (ayahuasca users vs. controls). df = degrees of freedom. Ayahuasca = ayahuasca-using group. HA = Harm
Avoidance; HA1-Anticipatory Worry vs. Uninhibited Optimism; HA2-Fear of Uncertainty vs. Confidence; HA3-Shyness with Strangers vs. Gregariousness; HA4-Fatigability
and Asthenia vs. Vigor; NS = Novelty Seeking; NS1-Exploratory Excitability vs. Stoic Rigidity; NS2-Impulsiveness vs. Reflection; NS3-Extravagance vs. Reserve; NS4-
Disorderliness vs. Regimentation; RD = Reward Dependence; RD1-Sentimentality vs. Insensitivity; RD3-Attachment vs. Detachment; RD4-Dependence vs. Independence;
P = Persistence; SD = Self-directedness; SD1-Responsibility vs. Blaming; SD2-Purposefulness vs. Lack of Goal-Direction; SD3-Resourcefulness; SD4-Self-Acceptance vs. Self-
Striving; SD5-Congruent Second Nature; C = Cooperativeness; C1-Social Acceptance vs. Social Intolerance; C2-Empathy vs. Social Disinterest; C3-Helpfulness vs.
Unhelpfulness; C4-Compassion vs. Revengefulness; C5-Integrated Conscience; ST = Self-Trascendence; ST1-Self-Forgetfulness vs. Self-Conscious Experience; ST2-
Transpersonal Identification vs. Self-Isolation; ST3-Spiritual Acceptance vs. Rational Materialism.
doi:10.1371/journal.pone.0042421.t002
Table 3. SCL-90-R subescales means (standard deviation).
First Assessment Second Assessment
ANOVA Jungle Sample Urban Sample ANOVA Jungle Sample Urban Sample
SCL-90-R df(1,221)
Ayahuasca
n=54
Controls
n=55
Ayahuasca
n=63
Controls
n=53 df(1,119)
Ayahuasca
n=32
Controls
n=46
Ayahuasca
n=30
Controls
n=15
GSI F = 23.59;
p,0.001
0.61
(0.63)
1.06
(0.59)
0.64
(0.57)
0.96
(0.61)
F = 7.28;
p = 0.008
0.49 (0.50) 0.95 (0.85) 0.59 (0.45) 0.81 (0.60)
PSDI F = 0.124;
p = 0.726
1.54
(0.52)
1.80
(0.54)
2.43
(7.26)
1.80
(0.56)
F = 0.95;
p = 0.333
1.40 (0.48) 2.47 (5.82) 1.52 (0.43) 1.81 (0.82)
PST F = 29.84;
p,0.001
31.17
(22.90)
50.33
(20.04)
32.46
(22.46)
45.08
(21.44)
F = 8.36;
p = 0.005
27.94 (19.91) 42.98 (22.01) 32.33 (19.45) 40.93 (22.26)
SOM F = 7.00;
p = 0.009
0.74
(0.88)
0.99
(0.76)
0.56
(0.65)
0.86
(0.76)
F = 2.13;
p = 0.147
0.63 (0.73) 0.85 (0.74) 0.53 (0.62) 0.72 (0.64)
O-C F = 19.76;
p,0.001
0.83
(0.73)
1.26
(0.75)
0.82
(0.69)
1.27
(0.77)
F = 9.40;
p = 0.003
0.68 (0.59) 1.13 (0.76) 0.81 (0.59) 1.20 (0.88)
I–S F = 16.76;
p,0.001
0.80
(0.71)
1.20
(0.72)
0.73
(0.59)
1.10
(0.81)
F = 12.45;
p = 0.001
0.52(0.52) 1.17 (0.78) 0.64 (0.43) 0.91 (0.90)
DEP F = 28.14;
p,0.001
0.58
(0.62)
1.13
(0.70)
0.65
(0.63)
1.04
(0.70)
F = 2.81;
p = 0.096
0.53 (0.58) 0.88 (0.65) 0.75 (0.66) 0.80 (0.60)
ANX F = 18.72;
p,0.001
0.43
(0.71)
0.89
(0.60)
0.48
(0.61)
0.78
(0.71)
F = 9.27;
p = 0.003
0.31 (0.46) 0.63 (0.59) 0.37 (0.52) 0.70 (0.54)
HOS F = 7.42;
p = 0.007
0.55 (0.65) 0.85 (0.73) 0.65 (0.84) 0.91 (0.77) F = 4.29;
p = 0.040
0.32 (0.38) 0.68 (0.79) 0.46 (0.62) 0.61 (0.57)
PHOB F = 20.23;
p,0.001
0.37 (0.58) 0.80 (0.63) 0.37 (0.52) 0.65 (0.66) F = 14.11;
p,0.001
0.22 (0.36) 0.58 (0.57) 0.26 (0.49) 0.65 (0.57)
PAR F = 10.95;
p = 0.001
0.78 (0.80) 1.21 (0.75) 0.86 (0.74) 1.11 (0.79) F = 7.35;
p = 0.008
0.53 (0.64) 1.04 (0.73) 0.71 (0.51) 0.92 (0.89)
PSY F = 10.09;
p = 0.002
0.48 (0.69) 0.89 (0.71) 0.62 (0.61) 0.79 (0.63) F = 4.21;
p = 0.042
0.44 (0.65) 0.78 (0.65) 0.52 (0.45) 0.68 (0.77)
The ANOVA column shows results for the main effect of Group (ayahuasca users vs. controls). df = degrees of freedom. Ayahuasca = ayahuasca-using group. GSI-
General Severity Index; PSDI-Positive Symptoms Distress Index; PST-Positive Symptoms Total; SOM-Somatization; O-C-Obsessive-Compulsive; I-S-Interpersonal
sensitivity; DEP-Depression, ANX-Anxiety, HOS-Hostility, PHOB-Phobic anxiety; PAR-Paranoid ideation; PSY-Psychoticism.
doi:10.1371/journal.pone.0042421.t003
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In the first assessment, ayahuasca users showed significantly
lower scores on all 9 psychopathological dimensions, as reflected
by a significant Group effect on Somatization [F(1,221) = 7.00;
p = 0.009], Obsessive-Compulsive [F(1,221) = 19.76; p,0.001],
Interpersonal Sensitivity [F(1,221) = 16.76; p,0.001], Depression
[F(1,221) = 28.14; p,0.001], Anxiety [F(1,221) = 18.72;
p,0.001], Hostility [F(1,221) = 7.42; p = 0.007], Phobic Anxiety
[F(1,221) = 20.23; p,0.001], Paranoid Ideation [F(1,221) = 10.95;
p = 0.001], and Psychoticism [F(1,221) = 10.09; p = 0.002].
The analysis of the additional indices also showed lower scores
on the General Severity (GSI) [F(1,221) = 23.59; p,0.001] and
Positive symptoms (PST) indices [F(1,221) = 29.84; p,0.001] and
no differences with controls regarding the Positive symptoms
distress index (PSDI).
In the second assessment, lower scores in the ayahuasca-using
group were again observed relative to the control subjects for 7 of
the 9 dimensions, i.e., Obsessive-Compulsive [F(1,119) = 9.40;
p = 0.003], Interpersonal Sensitivity [F(1,119) = 12.45; p = 0.001],
Anxiety [F(1,119) = 9.27; p = 0.003], Hostility [F(1,119) = 4.29;
p = 0.040], Phobic Anxiety [F(1,119) = 14.11; p,0.001], Paranoid
Ideation [F(1,119) = 7.35; p = 0.008], and Psychoticism
[F(1,119) = 4.21; p = 0.042]. Mean scores on Somatization and
Depression were lower for users than controls but the statistical
analysis did not show a significant Group effect. Results for the
additional indices replicated findings in the first assessment, with
significantly lower scores for users on the GSI [F(1,119) = 7.28;
p = 0.008] and the PST [F(1,119) = 8.36; p = 0.005] and no
differences in the PSDI.
4. Neuropsychological Performance and Behavior
Mean (SD) scores on neuropsychological tests for each sample,
group, and time point are shown in Table 4.
4.1. The Stroop Color and Word Test
In the first assessment, ayahuasca-using subjects obtained higher
scores on total words [F(1,235) = 21.00; p,0.001], total colors
[F(1,235) = 29.38; p,0.001], number of correctly read incongru-
Table 4. Stroop, Letter-Number Sequency Task, WSCT and FrsBe means (standard deviation).
First Assessment Second Assessment
ANOVA Jungle Sample Urban Sample ANOVA Jungle Sample Urban Sample
Stroop df(1,235)
Ayahuasca
n=56
Controls
n=56
Ayahuasca
n=71
Controls
n=56 df(1,136)
Ayahuasca
n=39
Controls
n=48
Ayahuasca
n=34
Controls
n=19
W F = 21.00;
p,0.001
86.36 (17.95) 77.38 (19,49) 94.11 (16.78) 82.27 (15.62) F = 8.48 p = 0.004 91.92 (17.58) 81.65 (19.73) 86.74 (17.75) 78.00 (16.11)
C F = 29.38;
p,0.001
62.20 (12.08) 57.09 (12.58) 69.27 (15.25) 55.09 (14.11) F = 2.88; p = 0.092 64.82 (12.58) 61.71 (9.91) 63.76 (13.39) 59.84 (9.46)
IW F = 31.15;
p,0.001
44.36 (18.81) 34.25 (8.68) 45.87 (13.78) 36.02 (11.70) F = 3.72; p = 0.056 42.23 (8.94) 37.21 (9.48) 39.06 (9.70) 37.95 (4.35)
RI F = 11.84;
p = 0.001
8.47 (16.99) 1.83 (7.88) 5.74 (9.48) 3.14 (6.75) F = 0.001; p = 0.974 4.37 (6.27) 2.30 (8.80) 2.57 (5.82) 4.72 (6.95)
WSCT df(1,238) n=56 n=56 n=71 n=59 df(1,134) n=37 n=47 n=35 n=19
N_tot F = 41.44;
p,0.001
39.52 (21.42) 54. 13 (19.80) 33.94 (16.16) 51.42 (20.12) F = 5.05; p = 0.026 22.97 (15.04) 36.72 (20.56) 37.65 (27.13) 41.16 (21.53)
N_pers F = 39.74;
p,0.001
21.02 (13.37) 30.98 (17.71) 18.13 (9.17) 31.59 (16.75) F = 3.62; p = 0.059 12.35 (8.61) 18.26 (10.63) 18.77 (14.50) 20.68 (11.66)
N_nonpers F = 12.40;
p = 0.001
17.93 (11.47) 22.86 (10.61) 15.92 (9.06) 20.36 (10.23) F = 4.43; p = 0.037 11.00 (7.72) 18.43 (12.26) 19.11 (13.69) 20.47 (11.98)
N_cat F = 0.093;
p = 0.761
4.61 (1.58) 3.63 (1.69) 5.25 (1.13) 5.59 (16.31) F = 1.52; p = 0.220 5.38 (1.88) 4.45 (1.90) 7.51 (21.09) 3.68 (2.19)
Fail F = 4.39;
p = 0.037
1.05 (1.20) 1.11 (1.00) 0.80 (1.10) 1.39 (1.40) F = 0.084; p = 0.773 1.30 (1.24) 1.57 (1.63) 1.57 (1.77) 1.68 (1.63)
LNS df(1,237) n=56 n=56 n=71 n=58 df(1.132) n=36 n=49 n=32 n=19
Score F = 21.27;
p,0.001
12.66 (3.95) 11.66 (3.73) 15.68 (3.36) 12.47
(3.06)***
F = 5.52; p = 0.020 11.64 (3.37) 10.29 (3.31) 9.91 (3.47) 8.42 (3.01)
FrSBe df(1,216) n=53 n=55 n=59 n=53 df(1,118) n=34 n=47 n=25 n=16
Apathy F = 23.79;
p,0.001
32.28 (5.96) 37.53 (6.64) 28.71 (6.67) 32.15 (7.03) F = 10.62; p = 0.001 27.85 (5.75) 31.70 (7.98) 24.48 (7.42) 30.06 (8.58)
Dishinibition F = 32.84;
p,0.001
31.19 (6.89) 37.13 (6.80) 26.93 (6.89) 32.38 (8.73) F = 4.05; p = 0.046 26.03 (7.70) 32.40 (8.67) 25.16 (7.17) 27.31 (9.33)
Executive
dysfunction
F = 11.20;
p = 0.001
39.25 (8.80) 41.60 (7.94) 35.53 (7.85) 40.89 (9.56) F = 7.04; p = 0.009 34.85 (7.15) 40.23 (9.64) 36.00 (15.05) 40.13 (15.67)
Total F = 31.81;
p,0.001
101.68
(17.07)
116.44
(18.55)
91.17 (17.96) 105.34 (22.16) F = 7.64; p = 0.007 88.74 (18.02) 104.83 (21.92) 82.12 (20.81) 89.63 (29.34)
The ANOVA column shows results for the main effect of Group (ayahuasca users vs. controls). df = degrees of freedom. Ayahuasca = ayahuasca-using group. W-Words;
C-Colors; IW-Color incongruent words; RI-Resistence to Interference. LNS = Letter-Number sequency; N_tot = number of total errors; N_pers= number of perseverative
errors; N_nonpers= number of non-perseverative errors; N_cat = number of achieved categores; Fail = failures no maintain set.
doi:10.1371/journal.pone.0042421.t004
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ent words [F(1,235) = 31.15; p,0.001] and resistance to interfer-
ence [F(1,235) = 11.84; p = 0.001].
In the second assessment, differences were only observed for
total words [F(1,136) = 8.48; p = 0.004]. A trend was observed
for the number of correctly read incongruent words
[F(1,136) = 3.72; p = 0.056] but not for total colors or resistance
to interference.
4.2. The Wisconsin Card Sorting Test (WCST)
The statistical analysis of the WCST in the first assessment showed
a significantly lower number of Total Errors [F(1,238) = 41.44;
p,0.001], Perseverative Errors [F(1,238) = 39.74; p,0.001], Non-
Perseverative Errors [F(1,238) = 12.40; p = 0.001] and Failures to
Maintain Set [F(1,238) = 4.39; p = 0.037] for the ayahuasca-using
subjects. No differences were found in the number of achieved
categories.
In the second assessment, the number of total errors was again
significantly lower [F(1,134) = 5.05; p = 0.026], as were the
number of Non-Perseverative Errors [F(1,134) = 4.43; p = 0.037].
Mean number of Perseverative Errors was also lower but only
showed a trend to significance in the analysis [F(1,134) = 3.62;
p = 0.059]. No differences were observed in Failures to Maintain
Set or in the Number of Achieved Categories.
4.3. The Letter-NumberSsequencing (LNS) from the
WAIS-III
The first assessment showed that ayahuasca users scored signifi-
cantly higher on this task than their controls [F(1,237) = 21.27;
p,0.001]. This difference was larger in the Urban sample, as
reflected in the Group by Sample interaction F(1,241) = 5.86;
p = 0.016].
One year later, in the second assessment, this overall effect
was observed [F(1,132) = 5.52; p = 0.020], but the interaction
was not.
4.4. The Frontal Systems Behaviour Scales (FrSBe)
In the first assessment, ayahuasca users showed lower values on the
total FrsBe score [F(1,216) = 31.81; p,0.001], on the Apathy/
Table 5. SOI, PLT, and BIEPS means (standard deviation).
First Assessment Second Assessment
ANOVA Jungle Sample Urban Sample ANOVA Jungle Sample Urban Sample
SOI df(1,216)
Ayahuasca
n=55
Controls
n=55
Ayahuasca
n=61
Controls
n=49 df(1,112)
Ayahuasca
n=34
Controls
n=43
Ayahuasca
n=25
Controls
n=14
Transcendent F = 153.54;
p,0.001
5.76
(0.97)
4.03
(1.00)
5.86
(1.03)
3.74 (1.55) F = 73.68;
p,0.001
5.84 (1.05) 4.04 (1.18) 5.87 (0.85) 3.78 (1.46)
Meaning F = 78.44;
p,0.001
5.77
(0.88)
4.88
(0.93)
5.91
(0.74)
4.57 (1.19) F = 33.88;
p,0.001
5.99 (0.63) 4.86 (1.00) 5.76 (0.79) 4.91 (0.84)
Mission F = 76.62;
p,0.001
5.64
(0.90)
4.67
(1.01)
5.55
(0.94)
4.21 (1.33) F = 38.56;
p,0.001
5.46 (1.03) 4.45 (1.00) 5.48 (1.01) 4.42 (1.60)
Sacredness F = 30.14;
p,0.001
5.96
(0.82)
5.10
(0.97)
6.09
(0.79)
4.72 (1.17) F = 39.83;
p,0.001
6.01 (0.80) 5.02 (0.99) 5.96 (0.84) 4.61 (1.18)
Material
values
F = 66.78;
p,0.001
4.95
(0.84)
4.40
(0.64)
4.82
(0.82)
4.19 (0.85) F = 21.82;
p,0.001
5.30 (0.62) 4.42 (0.54) 4.80 (0.63) 4.18 (0.51)
Altruism F = 19.32;
p,0.001
5.56
(0.86)
5.17
(0.91)
5.36
(0.92)
4.63 (1.10) F = 5.02;
p = 0.027
5.71 (0.90) 5.02 (1.06) 5.35 (0.82) 5.19 (0.76)
Idealism F = 25.59;
p,0.001
4.99
(0.59)
4.62
(0.54)
4.85
(0.60)
4.35 (0.78) F = 7.33;
p = 0.008
4.95 (0.60) 4.57 (0.52) 4.85 (0.69) 4.58 (0.63)
Awareness
Tragic
F = 48.64;
p,0.001
5.26
(1.01)
4.31
(1.05)
5.25
(1.60)
4.22 (1.07) F = 16.36;
p,0.001
5.20 (1.17) 4.40 (0.91) 5.02 (0.70) 4.20 (1.13)
Fruits of
spirituality
F = 91.03;
p,0.001
5.96
(0.79)
4.74
(1.21)
6.10
(0.85)
4.20 (1.81) F = 44.01;
p,0.001
5.96 (0.99) 4.81 (1.10) 5.98 (0.93) 4.22 (1.44)
PLT df(1,216) n=52 n=56 n=60 n=52 df(1,114) n=33 n=45 n=25 n=16
Score F = 14.10;
p,0.001
114.19
(14.69)
105.84
(16.64)
113.78
(14.61)
104.94
(21.34)
F = 1.78;
p = 0.185
116.36 (14.93) 109.80 (24.90) 116.56 (13.80) 113.63 (9.95)
BIEPS df(1,213) n=55 n=55 n=55 n=52 df(1,115) n=35 n=48 n=23 n=13
Self-
Acceptance
F = 7.46;
p = 0.007
8.24
(1.37)
7.95
(1.22)
8.18
(0.96)
7.52 (1.52) F = 0.50;
p = 0.481
8.17 (1.25) 8.23 (1.22) 8.48 (0.89) 8.08 (1.26)
Autonomy F = 1.89;
p = 0.17
7.27
(1.67)
7.29
(1.32)
7.33
(1.47)
6.75 (1.52) F = 0.85;
p = 0.358
7.46 (1.44) 7.02 (1.37) 7.09 (1.24) 7.00 (1.41)
Psychosocial
bonds
F = 7.75;
p = 0.006
8.33
(1.20)
8.11
(1.10)
8.31
(1.09)
7.54 (1.75) F = 4.10;
p = 0.045
8.57 (1.20) 8.06 (1.34) 8.78 (0.52) 8.31 (1.25)
Projects F = 6.01;
p = 0.015
11.05
(1.17)
10.51
(1.61)
10.87
(1.64)
10.38 (1.73) F = 1.28;
p = 0.260
11.03 (1.60) 10.50 (1.88) 11.17 (1.19) 12.85 (5.81)
BIEPS total F = 16.17;
p,0.001
34.89
(3.29)
33.85
(3.28)
35.44
(4.75)
32.12 (4.44) F = 6.33;
p = 0.013
35.17 (4.13) 33.81 (3.55) 35.48 (2.41) 32.46 (7.88)
The ANOVA column shows results for the main effect of Group (ayahuasca users vs. controls). df = degrees of freedom. Aya. = ayahuasca-using group. Transcendent-
Transcendent dimension; Meaning-Meaning and purpose in life; Mission-Mission in life; Sacredness-Sacredness of life; Awareness Tragic-Awareness of the tragic.
doi:10.1371/journal.pone.0042421.t005
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Akinesia scale [F(1,216) = 23.79; p,0.001] scale, on the Disinhibi-
tion/Emotional Dysregulation scale [F(1,216) = 32.84; p,0.001],
and on the Executive Dysfunction scale [F(1,216) = 11.20;
p = 0.001].
The same pattern of results was obtained in the second assessment.
Again lower values were obtained for the ayahuasca-using group,
with main Group effects on the total FrsBe score [F(1,118) = 7.64;
p = 0.007], on Apathy/Akinesia [F(1,118) = 10.62; p = 0.001], Dis-
inhibition/Emotional Dysregulation [F(1,118) = 7.04; p = 0.009]
and Executive Dysfunction [F(1,118) = 4.05; p = 0.046].
5. Subjective Life Attitudes
Mean (SD) scores on the different subscales of the 3 life
attitudes tests for each sample, group and time point are shown
in Table 5.
5.1. The Spiritual Orientation Inventory (SOI)
In the first assessment, ayahuasca users showed significantly
higher scores on all 9 components of the SOI, as revealed by a
main Group effect on Transcendent Dimension [F(1,216) = 153.54;
p,0.001], Meaning and Purpose in Life [F(1,216) = 78.44;
p,0.001], Mission in Life [F(1,216) = 76.62; p,0.001], Sacred-
ness of Life [F(1,216) = 30.14; p,0.001], Material Values
[F(1,216) = 66.78; p,0.001], Altruism [F(1,216) = 19.32;
p,0.001], Idealism [F(1,216) = 25.59; p,0.001], Awareness of
the Tragic [F(1,216) = 48.64; p,0.001], and Fruits of Spirituality
[F(1,216) = 91.03; p,0.001]. A significant Group by Sample
interaction was found for the latter dimension [F(1,216) = 4.45;
p = 0.036], with differences between users and controls being
larger in the Urban sample than in the Jungle sample.
In the second assessment, the pattern of results remained
unchanged, with higher scores on all components in the
ayahuasca-using subjects. Thus, significant Group effects were
found on Transcendent Dimension [F(1,112) = 73.68; p,0.001],
Meaning and Purpose in Life [F(1,112) = 33.88; p,0.001],
Mission in Life [F(1,112) = 38.56; p,0.001], Sacredness of Life
[F(1,112) = 38.83; p,0.001], Material Values [F(1,112) = 21.82;
p,0.001], Altruism [F(1,112) = 5.02; p = 0.027], Idealism
[F(1,112) = 7.33; p = 0.008], Awareness of the Tragic
[F(1,112) = 16.36; p,0.001], and Fruits of Spirituality
[F(1,112) = 44.01; p,0.001].
5.2. The Purpose in Life Test (PLT)
Higher scores on this test were found for the ayahuasca-using
subjects in the first assessment [F(1,216) = 14.10; p,0.001] but not
in the second assessment.
5.3. The Psychosocial Well-Being (BIEPS)
The statistical analysis in the first assessment showed signifi-
cantly higher values for ayahuasca users on the global BIEPS score
[F(1,213) = 16.17; p,0.001]. The difference between users and
controls was larger in the Urban, as shown by a significant Group
by Sample interaction [F(1,217) = 4.44; p,0.05]. With regard of the
individual dimension, users showed higher scores on Self-
Acceptance [F(1,213) = 7.46; p = 0.007], Psychosocial Bonds
[F(1,213) = 7.75; p = 0.006], and Projects [F(1,213) = 6.01;
p = 0.015]. No Group effect was found for the Autonomy
dimension.
In the second assessment, the Group effect on the global score
remained [F(1,115) = 6.33; p = 0.013], as did the effect on
Psychosocial Bonds [F(1,115) = 4.10; p = 0.045], but no other
main effect was found. However, a significant Group by Sample
interaction was found for Projects [F(1,19) = 4.75; p,0.05]
revealing lower values for the ayahuasca users as compared to
controls in the Urban sample.
Discussion
In this paper we present data from a field research study in
which personality, mental health, life attitudes and neuropsycho-
logical performance were assessed in a large number of ritual
ayahuasca users and their matched controls.
1 Personality
The TCI [49] was used to assess personality. Differences
between ayahuasca users and controls were found in several of the
temperament dimensions, which are believed to be genetically
determined. Higher scores on Reward Dependence (RD) may
reflect a feature allowing the group to adapt to a demanding
environment such as the tropical rainforest. This interpretation is
supported by the significant scores on the RD subdimensions
Attachment (RD3) and Dependence (RD4), but not Sentimentality
(RD1). This profile is probably useful for life in a small community
and in a hostile ecological environment. Participants in the Jungle
sample showed a trend to higher scores on Persistence than their
urban counterparts. Higher scores on this temperament dimension
could explain the adaptation capacity shown by these people to
their environment, and the ability to persist as a group despite
isolation. Additionally, Harm Avoidance (HA) was lower in the
ayahuasca-using subjects, probably reflecting the strength in
personality required to undergo regular ayahuasca sessions for
long periods of time. It is interesting to note that there were no
differences between groups in Novelty Seeking (NS) scores nor in
its subscales, including Impulsiveness (NS2). Since high scores in
NS and Impulsiveness have been associated with drug use [50,51],
the mere search for new experiences may not be the underlying
reason of their involvement with ayahuasca. On the contrary,
members of the ayahuasca religions report that the experiences
transcend the merely perceptual or recreational aspects of
psychoactive drug effects.
The analysis of Character dimensions showed that ayahuasca
users scored significantly higher in Self-Transcendence (ST). Since
all participants (users and controls) actively practiced some
religion, and Character traits can be influenced by personal
experience and culture, this finding could be interpreted as a direct
effect of ayahuasca use. Self-Directedness (SD), another Character
dimension, is consistently lower in the ayahuasca groups, and may
also be related to ayahuasca intake. Used in a religious context, the
potent psychotropic effects of ayahuasca may strengthen adher-
ence to the doctrine. The lower Self-Directedness (SD) scores
found may reflect the greater relevance of the community over the
individual. At the same time, there were no differences between
users and controls in Cooperativeness (C). So despite greater Self-
Transcendence and spirituality in the ayahuasca-using group,
willingness to cooperate with others was not different from that
seen in more conventional religions. It would be very interesting to
assess if subjects who have decided to leave the group and
discontinue ayahuasca use share personality traits with the long-
term users.
In a group of 15 long term urban ayahuasca users, Grob et al.
[28] found lower scores on NS and HA and no differences in RD
compared to 15 matched non-users, in line with our own results.
The higher RD scores in our study, driven mainly by the Jungle
sample, may reflect the difference in environment mentioned
above. Another research group has found changes in the
Temperament dimensions of the TCI after 6 months of regular
ayahuasca use in a religious setting in subjects who were initially
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naı¨ve to ayahuasca. However, these same subjects did not show
changes in the Character dimensions [52]. Based on these
findings, a less conservative explanation for the differences
observed in Temperament traits in the present study would be
that they are a consequence and not the cause of ritual ayahuasca
use. This would mean that ayahuasca may induce changes in
personality traits traditionally considered inherited. A recent study
in which high doses of psilocybin were administered in a
supportive setting showed positive long term changes in Openness
to Experiences [53]. This temperament trait is considered to be
the most substantially heritable trait in the Big Five personality
model, and relatively stable through adulthood [54].
2 Psychopathology
The analysis of psychopathology indicators showed the impor-
tant finding that ayahuasca users scored significantly lower on all
nine dimensions of the SCL-90-R. The two immediate explana-
tions for this finding are that either ayahuasca has a low potential
to induce psychopathology, or that samples of long-term users
suffer from a self-selection bias by which only those who do not
experience adverse psychological effects continue ayahuasca use.
Regarding the second explanation it is worth mentioning that at
follow-up lower scores were still seen on most dimensions, despite
the loss in sample size. Similar findings have been reported in the
literature. In a study where a group of 32 long term US ayahuasca
users were assessed with the same instrument, scores were
significantly lower than normative data for 7 of the 9 dimensions
[31]. Halpern et al. [55] did not find evidence either of
psychopathology in a group of peyote (a mescaline-containing
cactus) users when compared to controls. Grob et al. [28] did not
find evidence of psychopathology in their ayahuasca-taking sample
using the CIDI (Composite International Diagnostic Interview),
despite the fact that in the retrospective assessment most subjects
met criteria for psychiatric disorders prior to their religious use of
ayahuasca. Another study with teenage members of an ayahuasca
church did not find differences with the control group, but rather
showed a tendency to an improvement in some measures of
psychopathology [30]. Barbosa et al. [52,56] also failed to find
psychophatological symptoms both in the short-term after a first
ritual ayahuasca experience, and at follow up 6 months after
continued use. Some participants even showed a decrease in minor
psychopathological symptoms.
In summary, though there are case reports describing psychi-
atric complications following ayahuasca intake [24,25], it appears
that current long-term users do not show higher psychopathology.
One study reported that some experienced users even show
reduced scores of panic and hopelessness while under the effects of
the tea [57]. Future research should assess not only long-term users
but also ex-users to evaluate whether adverse psychological effects
play any role in the decision to discontinue use. The apparent
contradiction between reports of psychiatric crisis after acute
ayahuasca and the absence of psychopathology in many chronic
users should be studied in more detail.
One last consideration is the potential bias introduced by the
self-assessment nature of the SCL-90-R. Subjects may have been
inclined to give socially acceptable responses. However, scores on
the PST subscale were always higher than 3–4. According to the
interpretation norms for the SCL-90-R [58], low scores on this
subscale would be indicative of a social desirability bias. Further
support for the validity of our present findings is derived from
results in the neuropsychological assessment (see below). Psychi-
atric disorders are commonly accompanied by neuropsychological
deficits [59,60], but these were not observed in the ayahuasca-
using subjects in the present study.
3 Neuropsychological Functions
Based on the administered tests and the Frontal Systems
Behaviour Scales, we found no evidence of neuropsychological
impairment in the ayahuasca-using group. Furthermore, in
general terms they scored better than their respective comparison
groups and these differences were maintained one year later.
These results do not fit the hypothesis of potential frontal
impairment secondary to 5-HT2A receptor activation, and are
more in line with prior observations in users of psychedelics. Grob
et al. [28] found no working memory deficits in their sample of
ayahuasca users, but rather an improvement in one memory
subset. Da Silveira et al. [29] did not find deficits in the stroop and
other neuropsychological tests in their group of adolescent ritual
ayahuasca users. These users did not score differently than their
control group in most variables. They did fare worse on some
memory subtests, but results were within the normalcy range.
Halpern et al. [55] did not find neuropsychological impairment in
a group of long term peyote users from the Native American
Church. Tests included the Stroop test, the Wisconsin Card
Sorting Test and working memory tests. Although more research
is needed before definite conclusions can be drawn regarding this
drug class, based on the available evidence chronic use of
psychedelics does not seem to cause cognitive impairment.
The lack of cognitive impairment in our ayahuasca users can
not be attributed to a lack of sensitivity of the neuropsychological
tests administered, as they were sensitive enough to differentiate
between users and non users. The Stroop task and the Wisconsin
Card Sorting Test tap various cognitive functions such as selective
attention, behavioral inhibition, working memory and goal-
directed behavior, and are sensitive to PFC damage [61]. Also,
these same tests have been found to detect neuropsychological
impairment in various groups of drug abusers. For example, the
Wisconsin Card Sorting Test has proven sensitive to detect
flexibility impairments in non-addicted cocaine polydrug users
(between 1–4 gr. of cocaine per month). This population showed
more Perseverative Errors, fewer Categories Completed and worse
Conceptual Level Responses than matched controls [62]. Also, the
Stroop test was sensitive to detect executive dysfunctions in
individuals using alcohol [63], cocaine [64] and amphetamines
[65]. The same applies to the Letter-Number Sequencing task
[66]. However, the detection of differences between users and
non-users is known to be influenced by the length of the abstinence
period, the severity and duration of the addiction, the use of
multiple drugs and the presence of associated psychopathology
[67]. In any case, better performance in the drug-using group is
rarely found in the literature other than for the psychedelics.
Animal research has shown that 5-HT2A receptor activation plays
a role in normal neuropsychological and memory functioning [68–
71]. Another explanation for the present results has to do with
motivation. There is evidence that motivation may in fact improve
performance of drug users in neuropsychological tasks [72]. While
the recruited ayahuasca users may have been motivated to
demonstrate the safety of ayahuasca to researchers, the controls
did not obtain any specific benefit from their participation in the
study.
Concerning the capacity of the Frontal Systems Behaviour
Scales, a self-report questionnaire, to detect impairment, it is
worth noting that it has revealed deficits in non-addicted [73] and
addicted polydrug users [74,75]. The lower scores found for our
ayahuasca subjects on this measure of prefrontal deficits is
consistent with their better neuropsychological performance. This
result was found for both samples in the first assessment and in the
second.
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4. Life Attitude and Psychosocial Well-being
All SOI scores were consistently higher in both samples and
along time for the ayahuasca users, in consonance with scores on
the Self-Transcendence subscale of the TCI. Although a recent
study showed no significant differences in spiritually after an
ayahuasca session, the magnitude of the observed change was
positively correlated with the intensity of the peak of the
experience [76]. The qualitative data recorded revealed common
spiritual themes among participants [76]. In our first assessment,
ayahuasca users showed higher scores on Purpose in Life, although
this finding was not replicated one year later. This difference in
Purpose of Life may be understood as a consequence of the
religious use of ayahuasca, and is compatible with adherence to a
religious belief [77]. In line with the above results, ayahuasca users
scored higher on subjective psychological well-being. In a previous
report where these same participants were assessed on frequency
and degree of illicit drug use, ayahuasca users scored lower on the
different dimensions of the Addition Severity Index (ASI; [23]).
Taken together, the data point at better general mental health and
bio-psycho-social adaptation in the ayahuasca-using group com-
pared to the control subjects.
Limitations
The present study has several limitations. A relevant limitation
is that groups were not matched in premorbid IQ, so it is not
possible to know whether the differences found in the neuropsy-
chological tests are due to preexisting differences in cognitive
abilities or whether ayahuasca used in a ritual context is
responsible for the differences observed. Since neuropsychological
tasks, and especially working memory tests, are influenced by IQ
[78], future studies should control for this variable. From the
statistical point of view, the many variables analyzed may have
increased the occurrence of type I error. However, given the
difficulty of accessing ayahuasca-using populations we chose to
administer a comprehensive battery of tests and questionnaires. In
addition to the problems associated with self-report questionnaires
and the motivational aspects discussed above, a serious limitation,
at least in terms of psychopathology, may have been the self-
selection bias previously mentioned. Potentially, the assessed
individuals may have been those who did not experience any
negative neuropsychiatric consequences derived of their continued
ayahuasca use. Subjects experiencing adverse consequences may
have given up ayahuasca use altogether and may consequently not
be among the long-term users accessible to researchers. Future
investigation into the neuropsychiatric effects of ayahuasca use
should ideally also include people who used ayahuasca regularly in
the past but decided to discontinue its use.
Conclusion
The assessment of the impact of long-term ayahuasca use on
mental health from various perspectives (personality, psychopa-
thology, neuropsychology, life attitudes and psychosocial well-
being) did not find evidence of pathological alterations in any of
the spheres studied. Although ayahuasca-using subjects differed in
some personality traits, differences did not fit with a pathological
profile. Furthermore, ayahuasca users showed a lower presence of
psychopathological symptoms compared to controls. They per-
formed better in neuropsychological tests, scored higher in
spirituality and showed better psychosocial adaptation as reflected
by some attitudinal traits such as Purpose in Life and Subjective
Well-Being. Overall differences with the control group were still
observable at follow-up one year later.
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